Edited by Dmitry I. Gabrilovich, MD, PhD; Jennifer L. Guerriero, PhD; and Judith A. Varner, PhD
The special JITC series, Myeloid Cells in Immuno-oncology, developed in collaboration with The Myeloid Network, builds on the momentum and enthusiasm generated by prior jointly sponsored SITC Annual Meeting pre-conference workshops and programs focused on elucidating the mechanisms and therapeutic targeting of myeloid cells in immuno-oncology. This series features expert, in-depth reviews on the roles of myeloid cells and their metabolic regulation in cancer immunotherapy. Further, the series presents multiple expert perspectives on controversial and evolving areas in the field of myeloid biology. Collectively, these contributions aim to provide clarity to the complexity of myeloid cells within the tumor microenvironment, advance the biological understanding of myeloid cells, and inform the rational development of next-generation strategies to target myeloid cells to improve cancer outcomes.
View the introductory editorial and two review articles that have published in the series below. Check back throughout early 2026 for leading experts' perspectives and answers to provocative questions surrounding myeloid cells.